Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review
Electronic health records (EHRs) have emerged as resources for both the identification of adverse drug events (ADEs) and general population health surveillance, however questions remain around how best to utilize EHR data for drug safety signal identification. While the majority of signal identifica...
Saved in:
Main Authors: | Julie V. Kim (Author), Sharon E. Davis (Author), Michael E. Matheny (Author), Joshua C. Smith (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Postmarketing Surveillance: Review of Open Sources of Drug Safety Data
by: E. V. Shubnikova
Published: (2024) -
Open questions and research gaps for monitoring and updating AI-enabled tools in clinical settings
by: Sharon E. Davis, et al.
Published: (2022) -
Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease
by: Glenn T. Gobbel, et al.
Published: (2022) -
The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019) -
Boundary Matters: Uncovering the Hidden History of New York City's School Subdistrict Lines
by: Judith Kafka, et al.
Published: (2021)